QuaDMutEx: quadratic driver mutation explorer

被引:5
|
作者
Bokhari, Yahya [1 ]
Arodz, Tomasz [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Dept Comp Sci, Sch Engn, 401 W Main St, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA
来源
BMC BIOINFORMATICS | 2017年 / 18卷
基金
美国国家科学基金会;
关键词
Somatic mutations; Cancer pathways; Driver mutations; SOMATIC MUTATIONS; PASSENGER MUTATIONS; TUMOR-SUPPRESSOR; LUNG-CANCER; PATHWAYS; PROTEIN; GENE; RECEPTOR; KINASE; GROWTH;
D O I
10.1186/s12859-017-1869-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Somatic mutations accumulate in human cells throughout life. Some may have no adverse consequences, but some of them may lead to cancer. A cancer genome is typically unstable, and thus more mutations can accumulate in the DNA of cancer cells. An ongoing problem is to figure out which mutations are drivers - play a role in oncogenesis, and which are passengers - do not play a role. One way of addressing this question is through inspection of somatic mutations in DNA of cancer samples from a cohort of patients and detection of patterns that differentiate driver from passenger mutations. Results: We propose QuaDMutEx, a method that incorporates three novel elements: a new gene set penalty that includes non-linear penalization of multiple mutations in putative sets of driver genes, an ability to adjust the method to handle slow-and fast-evolving tumors, and a computationally efficient method for finding gene sets that minimize the penalty, through a combination of heuristic Monte Carlo optimization and exact binary quadratic programming. Compared to existing methods, the proposed algorithm finds sets of putative driver genes that show higher coverage and lower excess coverage in eight sets of cancer samples coming from brain, ovarian, lung, and breast tumors. Conclusions: Superior ability to improve on both coverage and excess coverage on different types of cancer shows that QuaDMutEx is a tool that should be part of a state-of-the-art toolbox in the driver gene discovery pipeline. It can detect genes harboring rare driver mutations that may be missed by existing methods. QuaDMutEx is available for download from https://github.com/bokhariy/QuaDMutEx under the GNU GPLv3 license.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] QuaDMutEx: quadratic driver mutation explorer
    Yahya Bokhari
    Tomasz Arodz
    BMC Bioinformatics, 18
  • [2] Cancer driver drug interaction explorer
    Hartung, Michael
    Anastasi, Elisa
    Mamdouh, Zeinab M.
    Nogales, Cristian
    Schmidt, Harald H. H. W.
    Baumbach, Jan
    Zolotareva, Olga
    List, Markus
    NUCLEIC ACIDS RESEARCH, 2022, 50 (W1) : W138 - W144
  • [3] Utility of driver mutation
    Sharma, V
    Patil, V. M.
    Noronha, V
    Joshi, A.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2016, 53 (03) : 365 - 365
  • [4] Inflammatory parameters in NSCLC with driver mutation
    Buyukbayram, Mehmet Emin
    Hannarici, Zekeriya
    Yilmaz, Ali
    Turhan, Aykut
    Caglar, Alperen Akansel
    Esdur, Pinar Coban
    Bilici, Mehmet
    Tekin, Salim Basol
    LUNG CANCER MANAGEMENT, 2024, 13 (01)
  • [5] Driver Mutation Profile By MLPA in Myelofibrosis Patients
    Juliana, Minuncio
    Nonino, Alexandre
    Mazzeu, Juliana Forte
    Mascarenhas, Cintia do Couto
    BLOOD, 2018, 132
  • [6] NSCLC Immunotherapy in Patients without Driver Mutation
    Freye, Reimund
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (12)
  • [7] ATRX driver mutation in a composite malignant pheochromocytoma
    Comino-Mendez, Inaki
    Tejera, Agueda M.
    Curras-Freixes, Maria
    Remacha, Laura
    Gonzalvo, Pablo
    Tonda, Raul
    Leton, Rocio
    Blasco, Maria A.
    Robledo, Mercedes
    Cascon, Alberto
    CANCER GENETICS, 2016, 209 (06) : 272 - 277
  • [8] Therapy for Driver Mutation Positive Advanced NSCLC
    Landi, Lorenza
    Cappuzzo, Federico
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S148 - S148
  • [9] BRAF mutation as a novel driver of eosinophilic cystitis
    Choi, Michael Y.
    Tsigelny, Igor F.
    Boichard, Amelie
    Skjevik, Age A.
    Shabaik, Ahmed
    Kurzrock, Razelle
    CANCER BIOLOGY & THERAPY, 2017, 18 (09) : 655 - 659
  • [10] Response to Mavacamten by Sarcomere Gene Mutation Status in EXPLORER-HCM
    Ho, Carolyn Y.
    Garcia-Pavia, Pablo
    Lakdawala, Neal K.
    Owens, Anjali T.
    Olivotto, Iacopo
    Blanes, Juan Ramon Gimeno
    Rincon, Luis M.
    Owens, David S.
    Charron, Philippe
    Cardim, Nuno
    Sehnert, Amy J.
    Anderson, Warren
    Landis, Jessica
    Wang, Zhaoqing
    Barriales-Villa, Roberto
    CIRCULATION, 2023, 148